Selected research
Industry Research
Comprehensive Solution for Molecular Testing Industry Research Report 2026
Market perspective
The global Comprehensive Solution for Molecular Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Comprehensive Solution for Molecular Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Comprehensive Solution for Molecular Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Comprehensive Solution for Molecular Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Comprehensive Solution for Molecular Testing include Roche Diagnostics, Thermo Fisher Scientific, Qiagen, Illumina, Bio-Rad Laboratories, Cepheid, BD, GenMark Diagnostics and Hologic, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Comprehensive Solution for Molecular Testing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Comprehensive Solution for Molecular Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Comprehensive Solution for Molecular Testing Market by Company
Roche Diagnostics
Thermo Fisher Scientific
Qiagen
Illumina
Bio-Rad Laboratories
Cepheid
BD
GenMark Diagnostics
Hologic
PerkinElmer
Hanchenguangyi Technology
Shenzhen Guangyu Biotechnology
Hangzhou Leyi Biotechnology
Flashdx
VivaChek Biotech
Comprehensive Solution for Molecular Testing Segment by Type
Nucleic Acid Amplification Testing
Protein Detection
Metabolite Detection
Others
Comprehensive Solution for Molecular Testing Segment by Application
Hospital
Research Institute
Others
Comprehensive Solution for Molecular Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Comprehensive Solution for Molecular Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Comprehensive Solution for Molecular Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Comprehensive Solution for Molecular Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Comprehensive Solution for Molecular Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Nucleic Acid Amplification Testing
- Protein Detection
- Metabolite Detection
- Others
Applications
- Hospital
- Research Institute
- Others
Companies covered
- Roche Diagnostics
- Thermo Fisher Scientific
- Qiagen
- Illumina
- Bio-Rad Laboratories
- Cepheid
- BD
- GenMark Diagnostics
- Hologic
- PerkinElmer
- Hanchenguangyi Technology
- Shenzhen Guangyu Biotechnology
- Hangzhou Leyi Biotechnology
- Flashdx
- VivaChek Biotech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Comprehensive Solution for Molecular Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Nucleic Acid Amplification Testing
- 2.2.3 Protein Detection
- 2.2.4 Metabolite Detection
- 2.2.5 Others
- 2.3 Comprehensive Solution for Molecular Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Research Institute
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Comprehensive Solution for Molecular Testing Breakdown Data by Type
- 3.1 Global Comprehensive Solution for Molecular Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Comprehensive Solution for Molecular Testing Forecasted Market Size by Type (2027-2032)
4 Comprehensive Solution for Molecular Testing Breakdown Data by Application
- 4.1 Global Comprehensive Solution for Molecular Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Comprehensive Solution for Molecular Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Comprehensive Solution for Molecular Testing Market Perspective (2021-2032)
- 5.2 Global Comprehensive Solution for Molecular Testing Growth Trends by Region
- 5.2.1 Global Comprehensive Solution for Molecular Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Comprehensive Solution for Molecular Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Comprehensive Solution for Molecular Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Comprehensive Solution for Molecular Testing Market Dynamics
- 5.3.1 Comprehensive Solution for Molecular Testing Industry Trends
- 5.3.2 Comprehensive Solution for Molecular Testing Market Drivers
- 5.3.3 Comprehensive Solution for Molecular Testing Market Challenges
- 5.3.4 Comprehensive Solution for Molecular Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Comprehensive Solution for Molecular Testing Players by Revenue
- 6.1.1 Global Top Comprehensive Solution for Molecular Testing Players by Revenue (2021-2026)
- 6.1.2 Global Comprehensive Solution for Molecular Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Comprehensive Solution for Molecular Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Comprehensive Solution for Molecular Testing Head Office and Area Served
- 6.4 Global Comprehensive Solution for Molecular Testing Players, Product Type & Application
- 6.5 Global Comprehensive Solution for Molecular Testing Manufacturers Established Date
- 6.6 Global Comprehensive Solution for Molecular Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Comprehensive Solution for Molecular Testing Market Size (2021-2032)
- 7.2 North America Comprehensive Solution for Molecular Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Comprehensive Solution for Molecular Testing Market Size by Country (2021-2026)
- 7.4 North America Comprehensive Solution for Molecular Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Comprehensive Solution for Molecular Testing Market Size (2021-2032)
- 8.2 Europe Comprehensive Solution for Molecular Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Comprehensive Solution for Molecular Testing Market Size by Country (2021-2026)
- 8.4 Europe Comprehensive Solution for Molecular Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Comprehensive Solution for Molecular Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Comprehensive Solution for Molecular Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Comprehensive Solution for Molecular Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Comprehensive Solution for Molecular Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Comprehensive Solution for Molecular Testing Market Size (2021-2032)
- 10.2 South America Comprehensive Solution for Molecular Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Comprehensive Solution for Molecular Testing Market Size by Country (2021-2026)
- 10.4 South America Comprehensive Solution for Molecular Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Comprehensive Solution for Molecular Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Comprehensive Solution for Molecular Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Comprehensive Solution for Molecular Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Comprehensive Solution for Molecular Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Roche Diagnostics
- 12.1.1 Roche Diagnostics Company Information
- 12.1.2 Roche Diagnostics Business Overview
- 12.1.3 Roche Diagnostics Revenue in Comprehensive Solution for Molecular Testing Business (2021-2026)
- 12.1.4 Roche Diagnostics Comprehensive Solution for Molecular Testing Product Portfolio
- 12.1.5 Roche Diagnostics Recent Developments
- 12.2 Thermo Fisher Scientific
- 12.2.1 Thermo Fisher Scientific Company Information
- 12.2.2 Thermo Fisher Scientific Business Overview
- 12.2.3 Thermo Fisher Scientific Revenue in Comprehensive Solution for Molecular Testing Business (2021-2026)
- 12.2.4 Thermo Fisher Scientific Comprehensive Solution for Molecular Testing Product Portfolio
- 12.2.5 Thermo Fisher Scientific Recent Developments
- 12.3 Qiagen
- 12.3.1 Qiagen Company Information
- 12.3.2 Qiagen Business Overview
- 12.3.3 Qiagen Revenue in Comprehensive Solution for Molecular Testing Business (2021-2026)
- 12.3.4 Qiagen Comprehensive Solution for Molecular Testing Product Portfolio
- 12.3.5 Qiagen Recent Developments
- 12.4 Illumina
- 12.4.1 Illumina Company Information
- 12.4.2 Illumina Business Overview
- 12.4.3 Illumina Revenue in Comprehensive Solution for Molecular Testing Business (2021-2026)
- 12.4.4 Illumina Comprehensive Solution for Molecular Testing Product Portfolio
- 12.4.5 Illumina Recent Developments
- 12.5 Bio-Rad Laboratories
- 12.5.1 Bio-Rad Laboratories Company Information
- 12.5.2 Bio-Rad Laboratories Business Overview
- 12.5.3 Bio-Rad Laboratories Revenue in Comprehensive Solution for Molecular Testing Business (2021-2026)
- 12.5.4 Bio-Rad Laboratories Comprehensive Solution for Molecular Testing Product Portfolio
- 12.5.5 Bio-Rad Laboratories Recent Developments
- 12.6 Cepheid
- 12.6.1 Cepheid Company Information
- 12.6.2 Cepheid Business Overview
- 12.6.3 Cepheid Revenue in Comprehensive Solution for Molecular Testing Business (2021-2026)
- 12.6.4 Cepheid Comprehensive Solution for Molecular Testing Product Portfolio
- 12.6.5 Cepheid Recent Developments
- 12.7 BD
- 12.7.1 BD Company Information
- 12.7.2 BD Business Overview
- 12.7.3 BD Revenue in Comprehensive Solution for Molecular Testing Business (2021-2026)
- 12.7.4 BD Comprehensive Solution for Molecular Testing Product Portfolio
- 12.7.5 BD Recent Developments
- 12.8 GenMark Diagnostics
- 12.8.1 GenMark Diagnostics Company Information
- 12.8.2 GenMark Diagnostics Business Overview
- 12.8.3 GenMark Diagnostics Revenue in Comprehensive Solution for Molecular Testing Business (2021-2026)
- 12.8.4 GenMark Diagnostics Comprehensive Solution for Molecular Testing Product Portfolio
- 12.8.5 GenMark Diagnostics Recent Developments
- 12.9 Hologic
- 12.9.1 Hologic Company Information
- 12.9.2 Hologic Business Overview
- 12.9.3 Hologic Revenue in Comprehensive Solution for Molecular Testing Business (2021-2026)
- 12.9.4 Hologic Comprehensive Solution for Molecular Testing Product Portfolio
- 12.9.5 Hologic Recent Developments
- 12.10 PerkinElmer
- 12.10.1 PerkinElmer Company Information
- 12.10.2 PerkinElmer Business Overview
- 12.10.3 PerkinElmer Revenue in Comprehensive Solution for Molecular Testing Business (2021-2026)
- 12.10.4 PerkinElmer Comprehensive Solution for Molecular Testing Product Portfolio
- 12.10.5 PerkinElmer Recent Developments
- 12.11 Hanchenguangyi Technology
- 12.11.1 Hanchenguangyi Technology Company Information
- 12.11.2 Hanchenguangyi Technology Business Overview
- 12.11.3 Hanchenguangyi Technology Revenue in Comprehensive Solution for Molecular Testing Business (2021-2026)
- 12.11.4 Hanchenguangyi Technology Comprehensive Solution for Molecular Testing Product Portfolio
- 12.11.5 Hanchenguangyi Technology Recent Developments
- 12.12 Shenzhen Guangyu Biotechnology
- 12.12.1 Shenzhen Guangyu Biotechnology Company Information
- 12.12.2 Shenzhen Guangyu Biotechnology Business Overview
- 12.12.3 Shenzhen Guangyu Biotechnology Revenue in Comprehensive Solution for Molecular Testing Business (2021-2026)
- 12.12.4 Shenzhen Guangyu Biotechnology Comprehensive Solution for Molecular Testing Product Portfolio
- 12.12.5 Shenzhen Guangyu Biotechnology Recent Developments
- 12.13 Hangzhou Leyi Biotechnology
- 12.13.1 Hangzhou Leyi Biotechnology Company Information
- 12.13.2 Hangzhou Leyi Biotechnology Business Overview
- 12.13.3 Hangzhou Leyi Biotechnology Revenue in Comprehensive Solution for Molecular Testing Business (2021-2026)
- 12.13.4 Hangzhou Leyi Biotechnology Comprehensive Solution for Molecular Testing Product Portfolio
- 12.13.5 Hangzhou Leyi Biotechnology Recent Developments
- 12.14 Flashdx
- 12.14.1 Flashdx Company Information
- 12.14.2 Flashdx Business Overview
- 12.14.3 Flashdx Revenue in Comprehensive Solution for Molecular Testing Business (2021-2026)
- 12.14.4 Flashdx Comprehensive Solution for Molecular Testing Product Portfolio
- 12.14.5 Flashdx Recent Developments
- 12.15 VivaChek Biotech
- 12.15.1 VivaChek Biotech Company Information
- 12.15.2 VivaChek Biotech Business Overview
- 12.15.3 VivaChek Biotech Revenue in Comprehensive Solution for Molecular Testing Business (2021-2026)
- 12.15.4 VivaChek Biotech Comprehensive Solution for Molecular Testing Product Portfolio
- 12.15.5 VivaChek Biotech Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst